1. The Role of a Low-Dose Ketamine-Midazolam Regimen in the Management of Severe Painful Crisis in Patients With Sickle Cell Disease 
Qutaiba A. Tawfic, MBChB, FIBMS, Ali S. Faris, MBChB, FIBMS, Rajini Kausalya, MD 
Journal of Pain and Symptom Management 
Volume 47, Issue 2, Pages (February 2014)
DOI: /j.jpainsymman
Copyright © 2014 U.S. Cancer Pain Relief Committee Terms and Conditions

2. Fig. 1
The daily requirement of intravenous morphine (milligram/day). D0=the day before intensive care unit (ICU) admission; D1–D5=days in ICU.
Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman )
Copyright © 2014 U.S. Cancer Pain Relief Committee Terms and Conditions

3. Fig. 2
The daily requirement of intravenous morphine. D0=the day before intensive care unit (ICU) admission; D1 and D2=the first and second day in ICU, respectively.
Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman )
Copyright © 2014 U.S. Cancer Pain Relief Committee Terms and Conditions

4. Fig. 3
The daily pain score. NRS=Numeric Rating Scale; D0=the day before intensive care unit (ICU) admission; D1 and D2=the first and second day in ICU, respectively.
Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman )
Copyright © 2014 U.S. Cancer Pain Relief Committee Terms and Conditions